Danmar Capital
VC Fund
Los Angeles, United States
Danmar Capital is a venture capital investment firm that is based in Beverly Hills, California and was founded in 2007. The firm invests in companies located in the United States.
- Total investments:
- 8
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Danmar Capital invests in
Stages Danmar Capital invests in
Countries Danmar Capital invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Ken Salkin
|
|||
4 more contacts available
Investment Focus
Industry
- Health Care 3 (38%)
- Medical Device 3 (38%)
- Biotechnology 2 (25%)
- Pharmaceutical 2 (25%)
- Artificial Intelligence 2 (25%)
Stage
- Seed 2 (25%)
- Series A 2 (25%)
- Pre-Seed 1 (13%)
- Series B 1 (13%)
- Series C 1 (13%)
Country
- United States 4 (50%)
- Israel 1 (13%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Ken Salkin
Managing Director
|
Managing Director | Total investments: 4 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Constru
|
Constru offers a breakthrough computer vision technology to superpower the engineering and project management teams onsite, monitoring every job, on every wall, throughout the construction process. The system collects and analyses photographic data and generates prescriptive insights to support business decisions and help the teams reliably delivertop-quality projects on time and on budget. | $8M / Series A / Sep 28, 2022 | |
Airway Therapeutics
|
Airway Therapeutics is an early stage development company that is licensing technology from within the pulmonary research program of Cincinnati Children's Hospital Medical Center (CCHMC) for further technology platform development. This platform will enable the development of three or more products that address various market needs in theoverall market for lung disorders. | $15.5M / Series C / Dec 05, 2019 | |
|
Airway Therapeutics
|
Airway Therapeutics is an early stage development company that is licensing technology from within the pulmonary research program of Cincinnati Children's Hospital Medical Center (CCHMC) for further technology platform development. This platform will enable the development of three or more products that address various market needs in theoverall market for lung disorders. | $10.9M / Series B / Mar 13, 2018 | |
Genetesis
|
Genetesis is a rapidly growing medical technology company redefining the way patients with a risk of myocardial ischemia and coronary artery disease are clinically diagnosed, monitored and screened. | $1.2M / Seed / Nov 14, 2016 | |
Init.ai
|
Init.ai enables companies to easily create AI and natural language conversational apps through our developer platform. We offer a comprehensive solution that handles messaging, machine learning, and business logic, including integration with third-party APIs. Acquired by Apple. | $100K / Seed / Feb 18, 2016 | |
Assurerx Health
|
Assurex Health is a personalized medicine company dedicated to helping clinicians determine the right medication for individual patients with medical conditions. Assurex Health’s proprietary Genesight® technology is based on pharmacogenomics – the study of the genetic factors that influence an individual’s response to drug treatments – as well asevidence-based medicine and clinical pharmacology. | $37.4M / Series D / Dec 23, 2014 | |
|
Airway Therapeutics
|
Airway Therapeutics is an early stage development company that is licensing technology from within the pulmonary research program of Cincinnati Children's Hospital Medical Center (CCHMC) for further technology platform development. This platform will enable the development of three or more products that address various market needs in theoverall market for lung disorders. | $4.7M / Series A / Sep 10, 2014 | |
|
Init.ai
|
Init.ai enables companies to easily create AI and natural language conversational apps through our developer platform. We offer a comprehensive solution that handles messaging, machine learning, and business logic, including integration with third-party APIs. Acquired by Apple. | Pre-Seed |
Co-Investors
Cincinnati Children’s
4 deals together
CincyTech
4 deals together
Queen City Angels
3 deals together
Allos Ventures
1 deal together
Ashtrom Group
1 deal together
boldstart ventures
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Danmar Capital invest in?
Danmar Capital invests primarily in Health Care, Medical Device and Biotechnology startups, most often at Seed and Series A stage. Most of the 8 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Danmar Capital?
For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Danmar Capital?
The team at Danmar Capital includes Ken Salkin (Managing Director). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
